{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:01:33Z","timestamp":1792292493841,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Anal fissure is caused by a pathological contraction of the internal anal sphincter. Lateral internal sphincterotomy remains the gold standard for the treatment of fissure. Botulinum toxin injections have been proposed to treat this condition without any risk of permanent injury of the internal sphincter. We investigate clinical and pathological variables and the effects of different dosage regimens of botulinum toxin to induce healing in patients with idiopathic anal fissure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective study at a single center. The patients underwent a pre-treatment evaluation that included clinical inspection of the fissure and anorectal manometry. We collected and analyzed demographic data, pathological variables, associated pathological conditions, and treatment variables. Success was defined as healing of the fissure, and improvement of symptoms was defined as asymptomatic persistent fissure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The findings of 1003 patients treated with botulinum toxin injections were reported. At 2\u00a0months evaluation, complete healing was evident in 780 patients (77.7%). Resting anal tone (77.1\u2009\u00b1\u200918.9\u00a0mmHg) was significantly lower from baseline (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and from 1-month value (<jats:italic>P<\/jats:italic>\u2009=\u20090.0008). Thirty-nine not healed patients underwent lateral internal sphincterotomy, and 184 were re-treated with 50 UI of botulinum toxin. In these patients, the healing rate was 93.9% (171 patients). Dose and injection site of toxin correlates with healing rate. There were no relapses during an average of about 71\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data show that injection of botulinum toxin into the internal anal sphincter is a safe and effective alternative to surgery in patients with chronic anal fissure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00384-022-04110-0","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T18:02:41Z","timestamp":1644602561000},"page":"693-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Botulinum toxin injection for the treatment of chronic anal fissure: uni- and multivariate analysis of the factors that promote healing"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8820-9471","authenticated-orcid":false,"given":"Giuseppe","family":"Brisinda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-0062","authenticated-orcid":false,"given":"Maria Michela","family":"Chiarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-7821","authenticated-orcid":false,"given":"Anna","family":"Crocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-095X","authenticated-orcid":false,"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-2567","authenticated-orcid":false,"given":"Maria","family":"Cariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-8225","authenticated-orcid":false,"given":"Serafino","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"4110_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/2050640616656708","volume":"5","author":"S Barbeiro","year":"2017","unstructured":"Barbeiro S, Atalaia-Martins C, Marcos P, Goncalves C, Canhoto M, Arroja B et al (2017) Long-term outcomes of Botulinum toxin in the treatment of chronic anal fissure: 5 years of follow-up. United European Gastroenterol J 5:293\u2013297","journal-title":"United European Gastroenterol J"},{"key":"4110_CR2","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00384-020-03699-4","volume":"35","author":"PA Boland","year":"2020","unstructured":"Boland PA, Kelly ME, Donlon NE, Bolger JC, Larkin JO, Mehigan BJ et al (2020) Management options for chronic anal fissure: a systematic review of randomised controlled trials. Int J Colorectal Dis 35:1807\u20131815","journal-title":"Int J Colorectal Dis"},{"key":"4110_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrgastro.2009.200","volume":"6","author":"G Brisinda","year":"2009","unstructured":"Brisinda G, Vanella S (2009) Chronic anal fissure: surgical or reversible neurochemical sphincterotomy? Nat Rev Gastroenterol Hepatol 6:694\u2013695","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4110_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1463-1318.2007.01388.x","volume":"10","author":"MS Sajid","year":"2008","unstructured":"Sajid MS, Hunte S, Hippolyte S, Kiri VA, Maringe C, Baig MK (2008) Comparison of surgical vs chemical sphincterotomy using botulinum toxin for the treatment of chronic anal fissure: a meta-analysis. Colorectal Dis 10:547\u2013552","journal-title":"Colorectal Dis"},{"key":"4110_CR5","doi-asserted-by":"crossref","unstructured":"Nelson RL, Thomas K, Morgan J, Jones A (2012) Non surgical therapy for anal fissure. Cochrane Database Syst Rev 2:CD003431","DOI":"10.1002\/14651858.CD003431.pub3"},{"key":"4110_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/codi.13969","volume":"20","author":"SM Sahebally","year":"2018","unstructured":"Sahebally SM, Meshkat B, Walsh SR, Beddy D (2018) Botulinum toxin injection vs topical nitrates for chronic anal fissure: an updated systematic review and meta-analysis of randomized controlled trials. Colorectal Dis 20:6\u201315","journal-title":"Colorectal Dis"},{"key":"4110_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00053-020-00497-y","volume":"42","author":"MM Chiarello","year":"2020","unstructured":"Chiarello MM, Cariati M, Brisinda G (2020) Botulinum toxin versus other therapies for treatment of chronic anal fissure. Coloproctology 42:457\u2013463","journal-title":"Coloproctology"},{"key":"4110_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00384-018-3087-6","volume":"33","author":"M Alawady","year":"2018","unstructured":"Alawady M, Emile SH, Abdelnaby M, Elbanna H, Farid M (2018) Posterolateral versus lateral internal anal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. Int J Colorectal Dis 33:1461\u20131467","journal-title":"Int J Colorectal Dis"},{"key":"4110_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00384-009-0683-5","volume":"24","author":"WJ Shao","year":"2009","unstructured":"Shao WJ, Li GC, Zhang ZK (2009) Systematic review and meta-analysis of randomized controlled trials comparing botulinum toxin injection with lateral internal sphincterotomy for chronic anal fissure. Int J Colorectal Dis 24:995\u20131000","journal-title":"Int J Colorectal Dis"},{"key":"4110_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.asjsur.2018.10.001","volume":"42","author":"T Acar","year":"2019","unstructured":"Acar T, Acar N, Gungor F, Kamer E, Gungor H, Candan MS et al (2019) Treatment of chronic anal fissure: is open lateral internal sphincterotomy (LIS) a safe and adequate option? Asian J Surg 42:628\u2013633","journal-title":"Asian J Surg"},{"key":"4110_CR11","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jviscsurg.2014.07.007","volume":"152","author":"T Higuero","year":"2015","unstructured":"Higuero T (2015) Update on the management of anal fissure. J Visc Surg 152:S37-43","journal-title":"J Visc Surg"},{"key":"4110_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/bjs.4531","volume":"91","author":"I Lindsey","year":"2004","unstructured":"Lindsey I, Jones OM, Cunningham C, Mortensen NJ (2004) Chronic anal fissure. Br J Surg 91:270\u2013279","journal-title":"Br J Surg"},{"key":"4110_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s00595-013-0785-0","volume":"44","author":"I Davies","year":"2014","unstructured":"Davies I, Dafydd L, Davies L, Beynon J (2014) Long term outcomes after lateral anal sphincterotomy for anal fissure: a retrospective cohort study. Surg Today 44:1032\u20131039","journal-title":"Surg Today"},{"key":"4110_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/codi.14466","volume":"21","author":"J Siddiqui","year":"2019","unstructured":"Siddiqui J, Fowler GE, Zahid A, Brown K, Young CJ (2019) Treatment of anal fissure: a survey of surgical practice in Australia and New Zealand. Colorectal Dis 21:226\u2013233","journal-title":"Colorectal Dis"},{"key":"4110_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0002-9270(03)00141-2","volume":"98","author":"MJ Utzig","year":"2003","unstructured":"Utzig MJ, Kroesen AJ, Buhr HJ (2003) Concepts in pathogenesis and treatment of chronic anal fissure\u2013a review of the literature. Am J Gastroenterol 98:968\u2013974","journal-title":"Am J Gastroenterol"},{"key":"4110_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1463-1318.2004.00641.x","volume":"6","author":"AP Zbar","year":"2004","unstructured":"Zbar AP, Pescatori M (2004) Functional outcome following lateral internal anal sphincterotomy for chronic anal fissure. Colorectal Dis 6:210\u2013211","journal-title":"Colorectal Dis"},{"key":"4110_CR17","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1111\/codi.12108","volume":"15","author":"P Garg","year":"2013","unstructured":"Garg P, Garg M, Menon GR (2013) Long-term continence disturbance after lateral internal sphincterotomy for chronic anal fissure: a systematic review and meta-analysis. Colorectal Dis 15:e104\u2013e117","journal-title":"Colorectal Dis"},{"key":"4110_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10151-014-1121-4","volume":"18","author":"HL Chen","year":"2014","unstructured":"Chen HL, Woo XB, Wang HS, Lin YJ, Luo HX, Chen YH et al (2014) Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Tech Coloproctol 18:693\u2013698","journal-title":"Tech Coloproctol"},{"key":"4110_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/DCR.0000000000000307","volume":"58","author":"H Gandomkar","year":"2015","unstructured":"Gandomkar H, Zeinoddini A, Heidari R, Amoli HA (2015) Partial lateral internal sphincterotomy versus combined botulinum toxin A injection and topical diltiazem in the treatment of chronic anal fissure: a randomized clinical trial. Dis Colon Rectum 58:228\u2013234","journal-title":"Dis Colon Rectum"},{"key":"4110_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/DCR.0000000000002194","volume":"64","author":"AR Bhama","year":"2021","unstructured":"Bhama AR, Zoccali MB, Chapman BC, Davids JS, Eisenstein S, Fish DR et al (2021) Practice variations in chemodenervation for anal fissure among American Society of Colon and Rectal Surgeons Members. Dis Colon Rectum 64:1167\u20131171","journal-title":"Dis Colon Rectum"},{"key":"4110_CR21","doi-asserted-by":"crossref","unstructured":"Borsuk DJ, Studniarek A, Park JJ, Marecik SJ, Mellgren A, Kochar K (2021) Use of botulinum toxin injections for the treatment of chronic anal fissure: results from an American Society of Colon and Rectal Surgeons Survey. Am Surg\u00a031348211023446","DOI":"10.1177\/00031348211023446"},{"key":"4110_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00384-011-1286-5","volume":"27","author":"E Yiannakopoulou","year":"2012","unstructured":"Yiannakopoulou E (2012) Botulinum toxin and anal fissure: efficacy and safety systematic review. Int J Colorectal Dis 27:1\u20139","journal-title":"Int J Colorectal Dis"},{"key":"4110_CR23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00384-012-1441-7","volume":"27","author":"G Brisinda","year":"2012","unstructured":"Brisinda G, Vanella S, Crocco A, Maria G (2012) Type A botulinum toxin treatment for chronic anal fissure. Int J Colorectal Dis 27:1543\u20131545","journal-title":"Int J Colorectal Dis"},{"key":"4110_CR24","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1007\/s00268-016-3693-9","volume":"40","author":"A Bobkiewicz","year":"2016","unstructured":"Bobkiewicz A, Francuzik W, Krokowicz L, Studniarek A, Ledwosinski W, Paszkowski J et al (2016) Botulinum toxin injection for treatment of chronic anal fissure: is there any dose-dependent efficiency? A Meta-Analysis. World J Surg 40:3064\u20133072","journal-title":"World J Surg"},{"key":"4110_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/164_2019_326","volume":"263","author":"M Cariati","year":"2021","unstructured":"Cariati M, Chiarello MM, Cannistra M, Lerose MA, Brisinda G (2021) Gastrointestinal uses of botulinum toxin. Handb Exp Pharmacol 263:185\u2013226","journal-title":"Handb Exp Pharmacol"},{"key":"4110_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1056\/NEJM199907083410201","volume":"341","author":"G Brisinda","year":"1999","unstructured":"Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 341:65\u201369","journal-title":"N Engl J Med"},{"key":"4110_CR27","doi-asserted-by":"crossref","unstructured":"Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G (2007) Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg\u00a094:162\u20137","DOI":"10.1002\/bjs.5514"},{"key":"4110_CR28","doi-asserted-by":"crossref","unstructured":"Brisinda G, Albanese A, Cadeddu F, Bentivoglio AR, Mabisombi A, Marniga G et al (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized \"Botox vs. Dysport\" controlled trial. Aliment Pharmacol Ther\u00a019:695\u2013701","DOI":"10.1111\/j.1365-2036.2004.01895.x"},{"key":"4110_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1586\/14737167.2014.924398","volume":"14","author":"G Brisinda","year":"2014","unstructured":"Brisinda G, Bianco G, Silvestrini N, Maria G (2014) Cost considerations in the treatment of anal fissures. Expert Rev Pharmacoecon Outcomes Res 14:511\u2013525","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4110_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5056\/jnm18172","volume":"25","author":"KD Keef","year":"2019","unstructured":"Keef KD, Cobine CA (2019) Control of motility in the internal anal sphincter. J Neurogastroenterol Motil 25:189\u2013204","journal-title":"J Neurogastroenterol Motil"},{"key":"4110_CR31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00000658-199811000-00005","volume":"228","author":"G Maria","year":"1998","unstructured":"Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (1998) Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens. Ann Surg 228:664\u2013669","journal-title":"Ann Surg"},{"key":"4110_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199801223380402","volume":"338","author":"G Maria","year":"1998","unstructured":"Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A (1998) A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 338:217\u2013220","journal-title":"N Engl J Med"},{"key":"4110_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOG.0000000000000599","volume":"36","author":"N Mathur","year":"2020","unstructured":"Mathur N, Qureshi W (2020) Anal fissure management by the gastroenterologist. Curr Opin Gastroenterol 36:19\u201324","journal-title":"Curr Opin Gastroenterol"},{"key":"4110_CR34","doi-asserted-by":"publisher","first-page":"O360","DOI":"10.1111\/codi.12615","volume":"16","author":"AE Berkel","year":"2014","unstructured":"Berkel AE, Rosman C, Koop R, van Duijvendijk P, van der Palen J, Klaase JM (2014) Isosorbide dinitrate ointment vs botulinum toxin A (Dysport) as the primary treatment for chronic anal fissure: a randomized multicentre study. Colorectal Dis 16:O360\u2013O366","journal-title":"Colorectal Dis"},{"key":"4110_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/gast.2002.34219","volume":"123","author":"M Minguez","year":"2002","unstructured":"Minguez M, Herreros B, Espi A, Garcia-Granero E, Sanchiz V, Mora F et al (2002) Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology 123:112\u2013117","journal-title":"Gastroenterology"},{"key":"4110_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1067\/msy.2002.119314","volume":"131","author":"G Brisinda","year":"2002","unstructured":"Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese A, Castagneto M (2002) Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 131:179\u2013184","journal-title":"Surgery"},{"key":"4110_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10151-017-1700-2","volume":"21","author":"P Ravindran","year":"2017","unstructured":"Ravindran P, Chan DL, Ciampa C, George R, Punch G, White SI (2017) High-dose versus low-dose botulinum toxin in anal fissure disease. Tech Coloproctol 21:803\u2013808","journal-title":"Tech Coloproctol"},{"key":"4110_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.870090106","volume":"9","author":"GE Borodic","year":"1994","unstructured":"Borodic GE, Ferrante R, Pearce LB, Smith K (1994) Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 9:31\u201339","journal-title":"Mov Disord"},{"key":"4110_CR39","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.4103\/jfmpc.jfmpc_944_19","volume":"9","author":"S Soltany","year":"2020","unstructured":"Soltany S, Hemmati HR, Toussy JA, Salehi D, Toosi PA (2020) Therapeutic properties of botulinum toxin on chronic anal fissure treatment and the patient factors role. J Family Med Prim Care 9:1562\u20131566","journal-title":"J Family Med Prim Care"},{"key":"4110_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10151-018-1821-2","volume":"22","author":"SA Pilkington","year":"2018","unstructured":"Pilkington SA, Bhome R, Welch RE, Ku F, Warden C, Harris S et al (2018) Bilateral versus unilateral botulinum toxin injections for chronic anal fissure: a randomised trial. Tech Coloproctol 22:545\u2013551","journal-title":"Tech Coloproctol"},{"key":"4110_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0002-9610(99)00255-X","volume":"179","author":"G Maria","year":"2000","unstructured":"Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 179:46\u201350","journal-title":"Am J Surg"},{"key":"4110_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/BF02555773","volume":"32","author":"AC Brown","year":"1989","unstructured":"Brown AC, Sumfest JM, Rozwadowski JV (1989) Histopathology of the internal anal sphincter in chronic anal fissure. Dis Colon Rectum 32:680\u2013683","journal-title":"Dis Colon Rectum"},{"key":"4110_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/bjs.1800830120","volume":"83","author":"WR Schouten","year":"1996","unstructured":"Schouten WR, Briel JW, Auwerda JJ, De Graaf EJ (1996) Ischaemic nature of anal fissure. Br J Surg 83:63\u201365","journal-title":"Br J Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-022-04110-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T17:18:40Z","timestamp":1646846320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-022-04110-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4110"],"URL":"https:\/\/doi.org\/10.1007\/s00384-022-04110-0","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"7 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki of 1975.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Each patient has been informed about the modalities and purposes of the treatment, providing, in all cases, written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}